Month: December 2021
-
Happy New Year. Here Are the Most-Viewed Stories for 2021
Here are the five most viewed editorial stories this year, counting down to number one.
-
Trial Underway Testing PTSD Drug Therapy
A clinical trial is underway testing an experimental drug to treat the underlying causes and symptoms of post-traumatic stress disorder or PTSD.
-
India Authorizes Covid-19 Vaccines Designed in US
The government of India granted emergency clearance to two vaccines to prevent Covid-19 disease, both designed in U.S. research labs.
-
Device Spin-Off Raises $2.2M in Seed Funds
A medical technology company developing a sensor device that monitors catheters draining excess brain fluid is raising $2.2 million in seed funds.
-
FDA Clears Rapid At-Home Covid-19 Test
The Food and Drug Administration granted an emergency authorization to a quick diagnostic test for SARS-CoV-2 viruses, conducted at home.
-
Infographic – How Americans Celebrate Christmas
The business research company Statista surveyed Americans on their different ways of noting the holiday, our infographic this weekend.
-
Essay – Quick, Name the Secretary of HHS
Our country and world are in the worst health crisis in a century, and the U.S. cabinet secretary with the word “health” in the title is missing in action.
-
Foundation Backing Expanded Pandemic Surveillance
A population genomics company is receiving foundation support for expanding its detailed surveillance of respiratory disease outbreaks in the U.S.
-
Trial Shows Results for Depression Drug with Therapy
Findings from a clinical trial show an experimental drug helps people in therapy for major depression reduce their symptoms compared to a placebo.
-
Engineered Chickpea with Increased Protein Unveiled
An agricultural biotechnology company is introducing genetically altered chickpeas with much higher protein content than today’s varieties.